ESG

Subsea 7 has landed a contract worth up to $300M for Chevron's Gorgon Stage 3 project, reinforcing its key role in Australia's deepwater energy sector.

Beyond Nordic hype, Helsinki's compact size and collaborative spirit are fostering a unique, accessible, and innovative culinary scene on its own terms.

Ayrmid and RoslinCT forge a key manufacturing pact for a new SAA therapy, revealing the critical infrastructure needed for resilient biotech returns.

A new Google-TotalEnergies deal in Malaysia reveals the collision of a data boom and green energy goals, a key test for the region's strategic future.

A new partnership between EcoFlow and Octopus Energy turns homes into automated power stations, slashing bills and reshaping the UK's energy grid.

A decade-long wait ends as the FDA approves a new 1st-line therapy for HER2+ breast cancer. See how ENHERTU reshapes patient outcomes and market dynamics.

A familiar quit-smoking app has been rebuilt into a powerful research tool, powering Australia's largest cessation trial and setting a new standard.

IO Biotech’s cancer vaccine posts impressive 5-year survival data, but a narrow miss in its pivotal trial creates an uncertain path in a competitive market.

Beijing touts its Sanjiangyuan project as a win for ecology and herders. But beyond the state narrative lies a complex story of coercion and cultural risk.

New rankings name Germany's top cancer hospitals, but the real story is the rise of platforms shaping a multi-billion dollar global health market.

CMS's new ACCESS model spotlights virtual care, positioning firms like FlyteHealth to lead a tech-driven transformation in managing chronic illness.

How a Defense Logistics Agency grant to 6K Energy for advanced cathode tech aims to sever risky foreign supply chains and secure America's defense.

A new partnership claims to power an AI with meditated 'love' from at-risk communities. Is this a bold new paradigm or a controversial social experiment?

SEG Solar's $80M Indonesian plant isn't just a new factory; it's a strategic move to build a non-FEOC solar supply chain for the United States.

Huntington Bank appoints veteran strategist Marc Dizard as CIO, signaling a major push to modernize its investment platform and challenge regional rivals.

A sustainable energy firm's bold move into digital assets signals a new era of institutional crypto adoption, driven by South Korean demand for Ripple.

Anixa Biosciences now fully controls its breast cancer vaccine after promising Phase 1 data. What does this strategic move mean for investors and medicine?

Odysight.ai's new sensors offer a live video feed from inside hot, oil-filled machinery, a breakthrough poised to transform industrial predictive maintenance.

A Minneapolis firm is testing a graft that helps the body rebuild its own arteries. This could end a painful, risky part of traditional heart bypass surgery.

With three major awards, NanaWall's new glass system reveals how deep engineering and market foresight are reshaping the value of architectural components.